In the April year 2018 Chief Directorate of medicines and medical equipment quality control, a subdivision of Ministry of Health in the Uzbekistan Republic has been approved Latvian oncolytic virotherapy medicine RIGVIR® for the treatment of cancer. In Uzbekistan, 23,000 new cases of cancer are discovered annually and Uzbek medical specialists highly appreciate the fact that now there is a safe, gentle and effective treatment available for cancer patients in Uzbekistan.